Resting and Dynamic Brain Glutamate by MRS In Vivo: Relation to Suicidal Behavior (Depression)
A Neuroimaging Study on Brain Chemistry in Depression
Sponsor: National Institute of Mental Health
Enrolling: Male and Female Patients
Study Length: 1 Months
Clinic Visits: 3
IRB Number: AAAV4037
Contact: Camila Gomez Restrepo: / cr3438@cumc.columbia.edu
Additional Study Information: We are conducting a study on depression and suicide risk, and participants can earn up to $300 for taking part. Suicide rates in the U.S. are rising, and new treatments are urgently needed. This study focuses on the brain chemical glutamate, which may play an important role in mood and mental health. We will compare glutamate levels at rest and during simple tasks in three groups: people with depression and past suicidal behavior, people with depression but no suicidal behavior, and healthy volunteers. Please email cr3438@cumc.columbia.edu for more information.
Investigator
Sarah Herzog, PhD
Do You Qualify?
Have you had ketamine in any form in the last 3 months? Yes No
Are you currently pregnant, breastfeeding, or trying to become pregnant? Yes No
Do you have a parent, child, or sibling with a history of schizophrenia? Yes No
Do you have conditions requiring daily use of stimulants, anxiety or sleep medications, antihistamines, or NSAIDs? Yes No
Are you currently depressed? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Camila Gomez Restrepo
cr3438@cumc.columbia.edu

This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE